Visualizing the evolution of evidence: Cumulative network meta-analyses of new generation antidepressants in the last 40 years

Visualizing the evolution of evidence: Cumulative network meta-analyses of new generation antidepressants in the last 40 years

It is often challenging to present the available evidence in a timely and comprehensible manner. We aimed to visualize the evolution of evidence about antidepressants for depression by conducting cumulative network meta‐analyses (NMAs) and to examine whether it could have helped the selection of opt...

Bibliografske podrobnosti
Main Authors:	Luo, Y, Chaimani, A, Furukawa, TA, Kataoka, Y, Ogawa, Y, Cipriani, A, Salanti, G
Format:	Journal article
Jezik:	English
Izdano:	Wiley 2020

Podobne knjige/članki

Evidence synthesis, practice guidelines and real-world prescriptions of new generation antidepressants in the treatment of depression: a protocol for cumulative network meta-analyses and meta-epidemiological study
od: Luo, Y, et al.
Izdano: (2018)

Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy.
od: Furukawa, T, et al.
Izdano: (2018)

Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis
od: Salanti, G, et al.
Izdano: (2018)

Cumulative network-meta-analyses, practice guidelines and actual prescriptions of drug treatments for postmenopausal osteoporosis: a study protocol for cumulative network meta-analyses and meta-epidemiological study
od: Kataoka, Y, et al.
Izdano: (2018)

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
od: Furukawa, T, et al.
Izdano: (2016)

Network meta-analyses should be the highest level of evidence in treatment guidelines
od: Leucht, S, et al.
Izdano: (2016)

Ranking antidepressants Reply
od: Cipriani, A, et al.
Izdano: (2009)

Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
od: Ogawa, Y, et al.
Izdano: (2017)

Network meta-analysis of antidepressants - Authors' reply
od: Cipriani, A, et al.
Izdano: (2018)

A dose-effect network meta-analysis model with application in antidepressants using restricted cubic splines
od: Hamza, T, et al.
Izdano: (2022)

Cumulative network meta-analyses, practice guidelines, and actual prescriptions for post-menopausal osteoporosis: a meta-epidemiological study
od: Kataoka, Y, et al.
Izdano: (2020)

Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.
od: Furukawa, T, et al.
Izdano: (2016)

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis
od: Cipriani, A, et al.
Izdano: (2018)

Comparative efficacy and acceptability of antidepressant drugs in the acute treatment of major depressive disorder: A network meta-analysis
od: Cipriani, A, et al.
Izdano: (2018)

Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials
od: Erick H. Turner, et al.
Izdano: (2022-01-01)

Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials.
od: Erick H Turner, et al.
Izdano: (2022-01-01)

Antidepressants might work for people with major depression: where do we go from here?
od: Cipriani, A, et al.
Izdano: (2018)

Allowing for uncertainty due to missing and LOCF imputed outcomes in meta‐analysis
od: Mavridis, D, et al.
Izdano: (2018)

DSM-III-R change in definition might have affected placebo response to antidepressants - Authors' reply
od: Cipriani, A, et al.
Izdano: (2017)

Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis
od: Tomlinson, A, et al.
Izdano: (2019)

Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal?
od: Barbui, C, et al.
Izdano: (2009)

Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review
od: Furukawa, T, et al.
Izdano: (2016)

Optimal dose of aripiprazole for augmentation therapy of antidepressant-refractory depression: preliminary findings based on a systematic review and dose-effect meta-analysis
od: Furukawa, Y, et al.
Izdano: (2021)

Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article
od: Chaimani, A, et al.
Izdano: (2017)

Individual differences in response to antidepressants: a meta-analysis of placebo-controlled randomized clinical trials
od: Maslej, MM, et al.
Izdano: (2021)

Combining endpoint and change data did not affect the summary standardised mean difference in pairwise and network meta‐analyses: An empirical study in depression
od: Ostinelli, EG, et al.
Izdano: (2024)

National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis
od: Luo, Y, et al.
Izdano: (2020)

Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol
od: Tomlinson, A, et al.
Izdano: (2019)

The Kilim plot: a tool for visualizing network meta-analysis results for multiple outcomes
od: Seo, M, et al.
Izdano: (2020)

Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol
od: Toshi A Furukawa, et al.
Izdano: (2020-05-01)

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
od: Cipriani, A, et al.
Izdano: (2009)

Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000–2020: a systematic review and meta-analysis
od: Lin, Y-H, et al.
Izdano: (2022)

Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey
od: Toshi A Furukawa, et al.
Izdano: (2024-05-01)

Antidepressants versus placebo for panic disorder in adults
od: Bighelli, I, et al.
Izdano: (2018)

Long-term treatment of depression with antidepressants: a systematic narrative review.
od: Furukawa, T, et al.
Izdano: (2007)

Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis.
od: Zhou, X, et al.
Izdano: (2018)

Evolution of Biocatalysis at Novartis over the last 40 Years
od: Elina Siirola, et al.
Izdano: (2023-06-01)

National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis
od: Yan Luo, et al.
Izdano: (2020-02-01)

Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis.
od: Cipriani, A, et al.
Izdano: (2007)

Evaluating heterogeneity in cumulative meta-analyses
od: Villanueva Elmer V, et al.
Izdano: (2004-07-01)